Efficient tumour formation by single human melanoma cells (original) (raw)

• Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345–349 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Li, C. et al. Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030–1037 (2007)
  Article CAS PubMed Google Scholar
• Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973–978 (2007)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Wu, C. et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67, 8216–8222 (2007)
  Article CAS PubMed Google Scholar
• Wang, J. C. et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91, 2406–2414 (1998)
  Article CAS PubMed Google Scholar
• Al-Hajj, M. et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Cox, C. V. et al. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104, 2919–2925 (2004)
  Article CAS PubMed Google Scholar
• Hope, K. J., Jin, L. & Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol. 5, 738–743 (2004)
  Article CAS Google Scholar
• Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA 104, 10158–10163 (2007)
  Article ADS CAS PubMed PubMed Central Google Scholar
• O’Brien, C. A. et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007)
  Article ADS PubMed CAS Google Scholar
• Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007)
  Article ADS CAS PubMed Google Scholar
• Williams, R. T., den Besten, W. & Sherr, C. J. Cytokine-dependent imatinib resistance in mouse BCR-ABL+, _Arf_-null lymphoblastic leukemia. Genes Dev. 21, 2283–2287 (2007)
  Article CAS PubMed PubMed Central Google Scholar
• Kelly, P. N. et al. Tumor growth need not be driven by rare cancer stem cells. Science 317, 337 (2007)
  Article ADS CAS PubMed Google Scholar
• Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257–268 (2006)
  Article CAS PubMed Google Scholar
• Agliano, A. et al. Human acute leukemia cells injected in NOD/LtSz-SCID/IL-γnull mice generate a faster and more efficient disease compared to other NOD/SCID-related strains. Int. J. Cancer 123, 2222–2227 (2008)
  Article CAS PubMed Google Scholar
• Feuring-Buske, M. et al. Improved engraftment of human acute myeloid leukemia progenitor cells in β-2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia 17, 760–763 (2003)
  Article CAS PubMed Google Scholar
• Kennedy, J. A. et al. Comment on ‘Tumor growth need not be driven by rare cancer stem cells’. Science 318, 1722; author reply 1722 (2007)
  Article ADS CAS PubMed Google Scholar
• Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895–902 (2003)
  Article CAS Google Scholar
• Wang, J. C. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494–501 (2005)
  Article CAS PubMed Google Scholar
• Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84–88 (2006)
  Article ADS CAS PubMed Google Scholar
• Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγ null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477–6489 (2005)
  Article CAS PubMed Google Scholar
• Ito, M. et al. NOD/SCID/γc null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100, 3175–3182 (2002)
  Article CAS PubMed Google Scholar
• McKenzie, J. L. et al. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 106, 1259–1261 (2005)
  Article CAS PubMed Google Scholar
• Shultz, L. D. et al. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells. Exp. Hematol. 31, 551–558 (2003)
  Article PubMed Google Scholar
• Hamada, K. et al. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rγnull (NOG) mice. Int. J. Oncol. 32, 153–159 (2008)
  CAS PubMed Google Scholar
• Suemizu, H. et al. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/γcnull (NOG) mice. Int. J. Oncol. 31, 741–751 (2007)
  CAS PubMed Google Scholar
• Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nature Biotechnol. 25, 1315–1321 (2007)
  Article CAS Google Scholar
• Kleinman, H. K. & Martin, G. R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15, 378–386 (2005)
  Article CAS PubMed Google Scholar
• Pretlow, T. G. et al. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res. 51, 3814–3817 (1991)
  CAS PubMed Google Scholar
• Sweeney, T. M. et al. Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases. Cancer Metastasis Rev. 10, 245–254 (1991)
  Article CAS PubMed Google Scholar
• Fridman, R. et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J. Natl Cancer Inst. 83, 769–774 (1991)
  Article CAS PubMed Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004)
  Article ADS CAS PubMed Google Scholar
• Iwashita, T. et al. Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301, 972–976 (2003)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Bao, S. et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 68, 6043–6048 (2008)
  Article CAS PubMed PubMed Central Google Scholar
• Frank, N. Y. et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65, 4320–4333 (2005)
  Article CAS PubMed Google Scholar
• Yilmaz, O. H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475–482 (2006)
  Article ADS CAS PubMed Google Scholar
• Horwich, A., Shipley, J. & Huddart, R. Testicular germ-cell cancer. Lancet 367, 754–765 (2006)
  Article CAS PubMed Google Scholar
• Kleinsmith, L. J. & Pierce, G. B. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544–1551 (1964)
  CAS PubMed Google Scholar
• Bonnefoix, T. et al. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J. Immunol. Methods 194, 113–119 (1996)
  Article CAS PubMed Google Scholar
• Nakajima, T. et al. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 50, 912–918 (1982)
  Article CAS PubMed Google Scholar
• Fernandez, Y. et al. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res. 65, 6294–6304 (2005)
  Article CAS PubMed Google Scholar
• Wang, Z. et al. Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells. Stem Cells 24, 1573–1582 (2006)
  Article CAS PubMed Google Scholar
• Bancroft, J. D. & Stevens, A. Theory and Practice of Histological Techniques (Churchill Livingstone, 1990)
  Google Scholar